Principal Investigators

    J.B Schulz, A.Voigt, F.Besse, M.Gama-Carvalho, J.De Las Rivas, J.Weis



    Contact information of lead PI



    Title of project or programme

    Fly-SMALS: Common RNA-dependent pathways for motor neuron degeneration in spinal muscular atrophy and amyotrophic lateral sclerosis

    Source of funding information

    JPND-Cross Disease

    Total sum awarded (Euro)

    € 762,991

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Motor neurone diseases|Spinal muscular atrophy (SMA)


    Research Abstract

    Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are characterized by degeneration of motor neurons. Both diseases are characterized by non-functional ribonucleic acid (RNA)/protein complexes and impaired neuronal RNA homeostasis, which might however be triggered by distinct mutations in the three conserved RNA- associated proteins TDP-43, FUS and SMN, respectively.
    We will test the hypothesis that neurodegeneration in ALS and SMA share common molecular pathways triggered by distinct mutations through a combination of genetic, biochemical and functional studies using transcriptomic/ proteomic and computational approaches. First we will assess which genes and splicing isoforms differ in ALS compared to SMA using drosophila fly models. We seek to determine the neuronal-specific RNA-protein and protein-protein interactions established by the drosophila homologues of the disease-causing proteins Fus, TDP-43 and SMN. We thereby aim to identify common neuronal gene networks or pathways and their contribution to disease progression.
    The findings will be translated to the human situation by verifying if the identified candidate genes are also mis- regulated in tissue derived from affected patients, with the goal of developing clinically relevant markers and therapeutic targets. This shall allow for reliable monitoring of ALS and SMA disease progression and the eventual development of biomarkers for early therapeutic intervention

    Lay Summary

    Further information available at:

Types: Investments > €500k, JPND Projects
Member States: France, Germany, JPND, Portugal, Spain
Diseases: Motor neurone diseases, Spinal muscular atrophy (SMA)
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF